Skip to main content

Animations

MJFF Publications

2621 - 2630 of 8571 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2017
  • 2023
  • 2018
  • 2018
  • 2023
  • 2018
  • 2016
  • 2016
  • Summary Details
    RESTRICTED
    Title: Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-019-0476-1
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Autophagic- and Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and Shadows
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells8111317
    Citation Count: 23
  • Summary Details
    RESTRICTED
    Title: Protein misfolding in neurodegenerative diseases: implications and strategies
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-017-0077-5
    Citation Count: 428
  • Summary Details
    RESTRICTED
    Title: Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass Spectrometry
    Journal Name: Molecular & Cellular Proteomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.mcpro.2023.100608
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: PAKs in the brain: Function and dysfunction
    Journal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.bbadis.2017.11.005
    Citation Count: 40
  • Summary Details
    RESTRICTED
    Title: Review: Somatic mutations in neurodegeneration
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/nan.12465
    Citation Count: 73
  • Summary Details
    RESTRICTED
    Title: Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid
    Journal Name: Nature Protocols
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41596-022-00787-3
    Citation Count: 35
  • Summary Details
    RESTRICTED
    Title: Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current options
    Journal Name: Behavioural Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbr.2017.12.014
    Best OA location URL:
    Citation Count: 20
  • Summary Details
    RESTRICTED
    Title: Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases
    Journal Name: Expert Opinion on Therapeutic Targets
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14728222.2016.1182990
    Citation Count: 42
  • Summary Details
    RESTRICTED
    Title: The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action
    Journal Name: Drug Discovery Today
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.drudis.2016.01.013
    Citation Count: 246
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.